Sarah’s Story: Managing Epilepsy with Medical Marijuana

The Weedcoin Team

How Cannabis Helped Reduce Seizures and Improve Quality of Life

For patients with epilepsy, finding effective treatments can be life-changing, and medical marijuana has offered hope for many. At Weedcoin, we’re sharing real patient stories through the MediWeed Hub with irie vibes to inspire and educate. In this article, we’ll dive into Sarah’s journey—a 28-year-old who turned to medical marijuana to manage her epilepsy after years of uncontrolled seizures. Her story highlights the potential of cannabis, particularly CBD-heavy strains, to reduce seizures and improve quality of life—let’s explore Sarah’s experience in detail!

Surreal illustration of a green brain with purple cannabis leaf floating in wavy purple sea with small figure

Sarah’s Diagnosis and Early Struggles


Sarah was diagnosed with epilepsy at age 12, experiencing frequent tonic-clonic seizures that disrupted her life. By her early 20s, she was having 5–10 seizures per month, despite trying multiple antiepileptic drugs (AEDs) like levetiracetam and valproate. These medications caused side effects like fatigue, mood swings, and weight gain, leaving Sarah feeling drained and hopeless. Her seizures made it difficult to maintain a job or social life—she often felt isolated, fearing a seizure in public. At 26, after another failed medication trial, Sarah’s neurologist suggested exploring medical marijuana, specifically CBD, which had shown promise for epilepsy in clinical studies.


Discovering Medical Marijuana


Sarah researched medical marijuana and learned that CBD (cannabidiol) could reduce seizures without the psychoactive effects of THC. The FDA has approved Epidiolex, a purified CBD product, for rare epilepsy forms like Dravet syndrome, reducing seizures by 39% in clinical trials. Sarah’s state (Colorado) had a robust medical cannabis program, and she consulted a cannabis-specialized doctor who recommended a high-CBD strain, Charlotte’s Web, known for its 20:1 CBD:THC ratio. She started with a low dose—5 mg CBD twice daily via a tincture—to assess her response, gradually increasing to 20 mg twice daily over a month. Sarah also ensured her products were lab-tested, confirming low THC levels (below 0.3%) to avoid psychoactivity.


Impact on Seizures and Quality of Life


Within two weeks, Sarah noticed a reduction in seizure frequency—from 5–10 per month to 2–3. After three months, her seizures dropped to 1–2 per month, a 70% reduction, aligning with research showing CBD’s efficacy. Sarah also experienced fewer side effects compared to AEDs—mild drowsiness was her only complaint, which subsided after adjusting her dose. Her quality of life improved dramatically—she felt more energetic, returned to part-time work as a graphic designer, and started socializing again without the constant fear of seizures. Sarah credits CBD with giving her a sense of normalcy, allowing her to plan her days without the unpredictability of epilepsy.


Challenges and Adjustments


Sarah faced challenges, including the cost of medical cannabis—her tinctures cost $80/month, not covered by insurance. She also had to experiment with dosing to find the right balance, as too much CBD (e.g., 50 mg at once) made her feel overly drowsy. To manage costs, Sarah joined a patient assistance program through her dispensary, reducing her expenses by 20%. She also learned to split her doses—10 mg in the morning and 10 mg at night—to maintain steady CBD levels without fatigue. Another challenge was navigating social stigma; some family members were skeptical of her cannabis use, associating it with recreational marijuana.
Sarah educated them using resources like the MediWeed Hub, explaining CBD’s non-psychoactive nature and its FDA approval for epilepsy. Over time, her family became supportive, seeing her improved health firsthand.


Long-Term Benefits and Lifestyle Changes


After a year of consistent use, Sarah’s seizures stabilized at 1 per month, and she reduced her AED dosage with her doctor’s guidance, minimizing side effects like mood swings. She also incorporated lifestyle changes to complement her treatment—practicing stress management through yoga and maintaining a regular sleep schedule, as stress and lack of sleep can trigger seizures.
Sarah experimented with other high-CBD strains, such as ACDC, to compare effects, finding that Charlotte’s Web remained the most effective for her. She also added a small amount of THC (1 mg) on particularly stressful days, finding that a 20:1 CBD:THC ratio provided mild relaxation without psychoactivity, aligning with research on the entourage effect.


Sarah’s Advice for Other Patients


Sarah emphasizes the importance of working closely with a doctor to find the right dose and strain—her neurologist monitored her liver function, as high CBD doses can affect liver enzymes.
She also recommends starting low and going slow, as outlined in the MediWeed Hub’s dosing guide, to avoid side effects like drowsiness. Sarah encourages patients to advocate for themselves, researching their state’s medical cannabis program and seeking out cannabis-specialized doctors if their primary physician is hesitant. Finally, she urges patients to join supportive communities like Weedcoin’s on X, where you can find encouragement and shared tips with others managing epilepsy.


Admiring Sarah’s Journey


We admire Sarah’s inspiring journey with epilepsy, as she transformed her challenges into a source of hope for others. Through determination and research, she discovered the benefits of a high-CBD strain, significantly reducing her seizures and reclaiming her quality of life. Sarah’s resilience shines as she shares her story, advocating for better access to medical cannabis for epilepsy patients. Her journey highlights the power of perseverance and the potential of cannabis to improve lives, inspiring others to explore its benefits with confidence.


Practical Tips



Key Takeaways


  • Sarah reduced her seizures by 70% using a high-CBD strain (Charlotte’s Web), aligning with research showing a 39% reduction. 
  • CBD improved her quality of life, allowing her to work and socialize without the side effects of traditional AEDs. 
  • Challenges included cost ($80/month) and initial drowsiness, managed through assistance programs and dose adjustments. 
  • Complementary lifestyle changes, like yoga and sleep hygiene, enhanced CBD’s effectiveness for seizure control. 
  • Weedcoin’s resources and community support empower epilepsy patients to share their treatment and advocate for others.
Glowing cross-section of a human brain with highlighted hippocampus region in warm golden light
By The Weedcoin Team April 14, 2026
A University of Colorado study of 26,000 adults found cannabis users aged 40 to 77 had larger brain volumes and faster processing speeds. Plus a migraine trial.
Empty New Jersey convenience store shelf where hemp products were displayed with dust outlines
By The Weedcoin Team April 13, 2026
A systematic review of 564 fibromyalgia patients found cannabis cut pain scores from 9.0 to 5.0 in six months. NJ hemp shelves go empty today. Seven days to 420.
Texas hemp shop restocking shelves after a judge blocked the statewide smokable hemp ban
By The Weedcoin Team April 12, 2026
A Texas judge blocked the hemp ban. Virginia's governor has until tomorrow. The Medicare CBD hearing lands on 420. And 50,000 people are headed to Denver for it.
Chalk pastel of a shadowy figure behind a frosted glass door with a cannabis leaf shadow
By The Weedcoin Team April 11, 2026
Roger Stone says someone inside the Trump administration is blocking cannabis rescheduling. Spanberger has two days. Massachusetts sent its bill to the governor.
By The Weedcoin Team April 10, 2026
Trump protects medical cannabis in his budget while blocking DC from legalizing. The FBI bans agents from cannabis but allows hemp unless the packaging has a leaf.
Doctor reviewing heart health ECG monitor data with a stethoscope on the desk in a clinic room
By The Weedcoin Team April 9, 2026
A 35-year CARDIA study found no link between cannabis and hypertension. But other major studies show acute cardiovascular risks. Here is the honest full picture.
Young autistic child laughing and building colorful blocks with their father in a sunlit playroom.
By The Weedcoin Team April 8, 2026
A Nature study tracked 82 autistic children on CBD-rich cannabis for six months. Social communication improved on gold-standard assessments. Here is the research.
Empty opioid pill bottles next to cannabis leaves and a recovery journal on a wooden table
By The Weedcoin Team April 7, 2026
New research: states with legal cannabis see a 9-11 point drop in daily opioid use. Over 70% of opioid withdrawal patients report meaningful relief from cannabis.
Elderly man with Parkinson's disease sitting peacefully with his family in a sunlit garden
By The Weedcoin Team April 6, 2026
A new case study shows THC oil reduced Parkinson's motor symptoms by 54.55% in an 83-year-old patient. Here is what the research on cannabis and Parkinson's shows.
Busy cannabis dispensary interior with customers browsing products under warm modern lighting
By The Weedcoin Team April 5, 2026
Legal cannabis revenue projected at $30.5 billion for 2026. Massachusetts fights ballot rollback. DC proposes cannabis-infused drinks. Cannabis skin conditions.
Digital screens displaying red cryptocurrency charts and blockchain data in a darkened trading room
By The Weedcoin Team April 4, 2026
A $280M exploit rattled the Solana ecosystem this week. Cannabis stocks are bleeding under tariff pressure. And CBD is showing real promise for brain injuries.
Elderly woman receiving CBD products from a pharmacist at a pharmacy counter with Medicare forms
By The Weedcoin Team April 3, 2026
A federal judge denied the injunction against Medicare CBD coverage. Trump tariffs are driving up cannabis costs. New Jersey's hemp ban hits in 10 days.
More Posts